APPROVABLE LETTERS IN THE FDA NEW DRUG APPROVAL PROCESS

被引：0
|
作者：
RICHARD, BW
ULCICKAS, M
LASAGNA, L
机构：
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 29卷 / 08期
关键词：
D O I：
10.1002/j.1552-4604.1989.tb03402.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：680 / 684
页数：5
相关论文
共 50 条
  • [31] Approvable letters for ligand, Datide
    不详
    BIOTECHNOLOGY LAW REPORT, 1999, 18 (01) : 42 - 43
  • [32] FDA provides fastest drug approval
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2012, 13 (07): : E287 - E287
  • [33] FDA drug approval summaries: Oxaliplatin
    Ibrahim, A
    Hirschfeld, S
    Cohen, MH
    Griebel, DJ
    Williams, GA
    Pazdur, R
    ONCOLOGIST, 2004, 9 (01): : 8 - 12
  • [34] LUPUS DRUG NEARS FDA APPROVAL
    不详
    CHEMICAL & ENGINEERING NEWS, 2010, 88 (47) : 17 - 17
  • [35] FDA Drug Approval and the Ethics of Desperation
    Largent, Emily A.
    Peterson, Andrew
    Lynch, Holly Fernandez
    JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1555 - 1556
  • [36] FDA drug approval summaries: Fulvestrant
    Bross, PF
    Cohen, MH
    Williams, GA
    Pazdur, R
    ONCOLOGIST, 2002, 7 (06): : 477 - 480
  • [37] Drug approval: Future aspects of the FDA
    Skelly, JP
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1998, 20 (06): : 527 - 537
  • [38] Overview of FDA Drug Approval and Labeling
    Clarridge, Katherine E.
    Chin, Stacy J.
    Stone, Kelly D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3051 - 3056
  • [39] FDA to slash drug approval times
    不详
    CHEMISTRY & INDUSTRY, 2003, (13) : 5 - 5
  • [40] FDA accelerates drug approval system
    Scott, A
    CHEMICAL WEEK, 2004, 166 (32) : 42 - 42
12345